In the News

Stay up to date with the latest news from Providence Cancer Institute Oregon. Sign up for our monthly research newsletter.

Follow us on social media:

2/26/2024
Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.
2/26/2024
The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).
2/12/2024
Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.
2/9/2024
In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.
2/1/2024
Providence Cancer Institute registered dietitian to present a free virtual education talk on nutrition in March.
1/24/2024
New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy
1/10/2024
"Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.
12/15/2023
New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.
1/10/2024
Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.
12/13/2023
Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.
11/20/2023
A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.
11/3/2023
Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.
11/20/2023
SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.
Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.
10/12/2023
Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.
10/4/2023
Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.
2/21/2024
Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.
9/22/2023
Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.
9/18/2023
For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.
8/18/2023
New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.
7/10/2023
A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.
7/3/2023
Final outcomes from a Providence Cancer Institute-sponsored phase Ib trial evaluating pembrolizumab with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic TNBC.
6/28/2023
Researchers from Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, shared their investigations to advance cancer research and treatments at the premier event.
8/16/2023
Portland painter credits the support of Providence providers and creating art for helping her recover and heal from breast cancer and the loss of her mother.
9/26/2023
Virtual talks at Providence highlight MRI-guided radiation therapy for treating breast cancer, pancreatic cancer treatments, and sexual health during and after ovarian cancer.
5/15/2023
New investigator-initiated trial at Providence to evaluate a triple combination of medications for treating melanoma, and two new studies evaluating medication combinations to treat AML.
5/17/2023
Providence researchers awarded an R21 grant from the National Institutes of Health which provides funding for projects with potential to significantly advance biomedical research.
5/11/2023
A free virtual online class hosted by Providence Cancer Institute will highlight what to eat during cancer treatments, how to manage side effects and how to speed healing.
4/27/2023
Physician scientist Sasha Stanton, M.D., Ph.D., shares her career journey to medical oncology and breast cancer research at Providence Cancer Institute.
5/19/2023
Cancer survivor Jeff Newell shares his experiences as a volunteer at Providence Cancer Institute and how he uses his own cancer journey to impart hope to others.